CD274 and neoplasm: Furthermore, biomarker analysis using tumor biopsy samples showed that patients with tumors that expressed programmed cell death 1 ligand 1 (PD-L1) and who exhibited tumor-infiltrating lymphocytes (TILs) at baseline had higher pCR rates, suggesting that the efficacy of IRT is strongly predicted by the patient’s immune microenvironment.